Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/2012
05/09/2012CN102448494A Immunoconjugates with an intracellularly-cleavable linkage
05/09/2012CN102448493A Treatment of insulin-resistant disorders
05/09/2012CN102448492A Anti-TROP-2 monoclonal antibodies and uses thereof in the treatment and diagnosis of tumors
05/09/2012CN102448491A Vaccine compositions and methods of use thereof
05/09/2012CN102448490A Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
05/09/2012CN102448489A Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
05/09/2012CN102448488A Vaccine for mycoplasma infection
05/09/2012CN102448487A Vaccination methods
05/09/2012CN102448486A Antibody drug conjugates (ADC) that bind to 24p4c12 proteins
05/09/2012CN102448485A Immunogenic composition and uses thereof
05/09/2012CN102448459A Use of multi-kinase inhibitors in the treatment of vascular hyperpermeability
05/09/2012CN102443603A Replication-defective A virus expression vector system and vaccine preparation method
05/09/2012CN102443594A Receptor activator of nuclear factor kappa B ligand (RANKL)-HBaAg expression constructing object, yeast, manufacture method as well as application
05/09/2012CN102443572A Method for purifying detoxified pertussis vaccine antigen solution
05/09/2012CN102443571A Chicken-origin H9N2 avian influenza virus strain and application thereof
05/09/2012CN102443552A Porcine actinobacillus pleuropeumoniae ClpP protease gene-deleted strain containing no resistance marker, construction method thereof, and application thereof
05/09/2012CN102443543A Anti-white-spot-syndrome-virus transgenic algae strain as well as preparation method and application thereof
05/09/2012CN102443063A Anti-TNFalpha humanized Fab, humanized antibody and its application
05/09/2012CN102443062A Human brain tissue specific gene LRRC4 monoclonal antibody, its preparation and application method
05/09/2012CN102443061A High-functional antibody biological synthesis
05/09/2012CN102443060A Anti-HPV (human papilloma virus) antibody and preparation method and application thereof
05/09/2012CN102443056A Exon deleted variant of epidermal growth factor receptor
05/09/2012CN102443053A Application of using streptococcus suis type-2 hy0245 gene encoded proteins as protective antigens
05/09/2012CN102443052A Peptide of HIV for adjusting or aiding protein, compositions and the application thereof
05/09/2012CN102441174A DNA vaccines against hantavirus infections
05/09/2012CN102441173A Preparation method of a drug release system with water-insoluble protein powder as drug carrier
05/09/2012CN102441166A Application of monoclonal antibody in treating head and neck neoplasm
05/09/2012CN102441165A Application of monoclonal antibody in treating esophageal cancer
05/09/2012CN102441164A Application of monoclonal antibody for treating colorectal cancer
05/09/2012CN102441163A Tweak binding antibodies
05/09/2012CN102441162A Treatment and prevention of tuberculosis
05/09/2012CN101880651B Preparation method of Muscovy duck parvo novel vaccines
05/09/2012CN101862450B Recombinant bacillus calmette-guerin vaccine secreting bacteria resuscitation somatomedin and application thereof
05/09/2012CN101831434B Anti-human CD45RA rat immune globulin variable region gene and application
05/09/2012CN101818133B VSIG4 (V-set and Ig domain containing 4) and IGRP (glucose-6-phosphatase catalytic subunit-related protein) dual-gene coexpression recombinant adenovirus as well as preparation method and application thereof
05/09/2012CN101633909B Attenuated live vaccine strain for preventing pig-pig infection breeding and respiratory syndrome
05/09/2012CN101623498B Dual-target tumor vaccine based on tumor endothelium marker-8 gene and preparation method thereof
05/09/2012CN101554476B Aftosa vaccine immunopotentiator
05/09/2012CN101549155B Porcine circovirus type II inactivated vaccine and method for preparing same
05/09/2012CN101343319B Anti-dengue virus E protein monoclone antibody, preparation method and uses thereof
05/09/2012CN101260148B Hybrid and tandem expression of neisserial proteins
05/09/2012CN101146532B Pharmaceutical compounds
05/09/2012CN101072797B Antibody binding EPHB4, inhibiting angiogenesis and tumor growth
05/09/2012CN101014620B Antibodies against clostridium difficile toxins and uses thereof
05/08/2012US8173798 Vaccine
05/08/2012US8173781 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
05/08/2012US8173779 Neutralizing human anti-IGFR antibody
05/08/2012US8173774 Polypeptides and use thereof
05/08/2012US8173767 Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV
05/08/2012US8173657 Imidazoquinoxaline compounds as immunomodulators
05/08/2012US8173640 Compositions and methods for treating, reducing, ameliorating, or preventing infections
05/08/2012US8173613 Modulation of mesenchymal and metastatic cell growth
05/08/2012US8173424 Internalizing ErbB2 antibodies
05/08/2012US8173411 Drying process for preserving an active agent as a highly viscous liquid
05/08/2012US8173383 Methods and materials for the detection of Leishmania infection
05/08/2012US8173372 Methods of donor specific crossmatching
05/08/2012US8173141 Immunogenic complexes and methods relating thereto
05/08/2012US8173140 Compositions and methods for activating innate and allergic immunity
05/08/2012US8173139 High energy electron beam irradiation for the production of immunomodulators in poultry
05/08/2012US8173138 Stable liquid formulations of botulinum toxin
05/08/2012US8173137 Polycistronic HIV vector constructs
05/08/2012US8173136 Attenuated recombinant newcastle disease virus and vaccine containing the same
05/08/2012US8173135 Methods for preparing complex multivalent immunogenic conjugates
05/08/2012US8173134 ECD carboxy-terminal deletion FGFR4 fusion proteins and methods of producing them
05/08/2012US8173133 Acyl pseudodipeptides which carry a functionalized auxiliary arm
05/08/2012US8173132 Exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers; used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 213P1F11 can be used in active or passive immunization.
05/08/2012US8173131 Compositions and methods for modulating RSV infection and immunity
05/08/2012US8173130 Antibodies against flagellin and uses thereof
05/08/2012US8173129 Methods and compositions for treating autoimmune diseases
05/08/2012US8173128 Methods and compositions for inducing apoptosis in cancer cells with an anti-DR5 antibody
05/08/2012US8173127 Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
05/08/2012US8173126 Blood VEGF level-lowering agent containing IL-6 antagonist as the active ingredient
05/08/2012US8173125 Wise/Sost nucleic acid sequences and amino acid sequences
05/08/2012US8173124 Method to treat using antagonistic anti-hTNFSF13b human antibodies
05/08/2012US8173123 Methods of treating colitis involving IL-13 and NK-T cells
05/08/2012US8173122 Methods of treatment using antibodies to neutrokine-alpha
05/08/2012US8173117 Mouse CX3C chemokine polypeptides
05/08/2012US8173104 Controlled-release immunogenic formulations to modulate immune response
05/08/2012CA2623339C Virulence genes in the vgc2 cluster of salmonella
05/08/2012CA2533581C Vaccine formulations comprising an oil-in-water emulsion
05/08/2012CA2473135C Stabilised mrna tumour vaccine
05/08/2012CA2469334C Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
05/08/2012CA2460042C Inhibition of antigen presentation with poorly catabolized polymers
05/08/2012CA2421447C Collections of repeat proteins comprising repeat modules
05/08/2012CA2368184C Method and means for treating post-polio syndrome
05/08/2012CA2362264C Cytokine-binding domain
05/08/2012CA2350064C Chimeric anti-cd20 antibody treatment of patients receiving bmt or pbsc transplants
05/08/2012CA2284271C A preventive or therapeutic agent for sensitized t cell-mediated diseases comprising il-6 antagonist as an active ingredient
05/08/2012CA2229741C Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
05/08/2012CA2163211C Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
05/08/2012CA1341629C Hepatitis c diagnostics and vaccines
05/03/2012WO2012058673A2 Enhanced cancer treatment and monitoring using recombinant vectors
05/03/2012WO2012058642A2 Use of sam68 for modulating signaling through the tnf receptor
05/03/2012WO2012058592A2 Non-antagonistic egfr-binding molecules and immunoconjugates thereof
05/03/2012WO2012058588A2 Novel egfr-binding molecules and immunoconjugates thereof
05/03/2012WO2012058493A2 Recombinant hemagglutinin protein of influenza virus and vaccine containing the same
05/03/2012WO2012058492A2 Viral vaccine and process for preparing the same
05/03/2012WO2012058460A2 Chimeric cd27 receptors for redirecting t cells to cd70-positive malignancies
05/03/2012WO2012058418A2 Compositions targeting the soluble extracellular domain of e-cadherin and related methods for cancer therapy
05/03/2012WO2012058363A2 Recombinant envelope protein of human immunodeficiency virus (hiv) and vaccine containing the same
1 ... 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 ... 1823